Report Company Directory

ONWARD MEDICAL NV

• Morning Notes : BARb BB, CRBN NA, EXMb BB, QFG BB, ONWD BB by KBC Securities
• Onward Medical FIRST LOOK: 1Q25 confirms ARC-EX' initial sales traction by KBC Securities
• ONWARD Medical Builds Commercial Momentum for the ARC-EX System and Reinforces its Brain-Computer Interface Leadership in Q1 2025 by GlobeNewsWire
• ONWARD Medical Announces Results of its Annual General Meeting of Shareholders by GlobeNewsWire
• ONWARD Medical Schedules Webcast to Provide Q1 2025 Business Update and Year-To-Date Highlights by GlobeNewsWire
• Onward Medical FIRST LOOK: Two additional BCI implants completed by KBC Securities
• Morning Notes : ATEB BB, ELI BB, CMBT BB, GREEN BB, HOMI BB, IBAB BB, ONWD BB by KBC Securities
• ONWARD Medical Advances Brain-Computer Interface Leadership with Fourth and Fifth Successful BCI Implants by GlobeNewsWire
• ONWARD Medical Convocation of the 2025 Annual General Meeting of Shareholders and Proposed Resolutions by GlobeNewsWire
• ONWARD Medical Announces Release of 2024 Annual Report by GlobeNewsWire

ONWARD OPPORTUNITIES LIMITED

• European Morning Research Summary by Stifel
• Q1 review: First commercial quarter gives confidence in FY target with a rich clinical H2 backdrop by Stifel
• Suspension of coverage by Bryan Garnier
• ONWARD: Expanding BCI clinical evidence with 5th implant milestone by Bryan Garnier
• ONWARD: BCI in action – Lausanne visit takeaways by Bryan Garnier
• ONWARD: from brainGPT to ARC-BCI – fireside chat with the founders by Bryan Garnier
• ONWARD: Opening the door to US investors with OTCQX ADR listing by Bryan Garnier
• Stifel Q1-25 Quarterly Research Digest by Stifel
• European Morning Research Summary by Stifel
• ONWARD: FY24 Update – Commercial inflection begins, near-term milestones ahead by Bryan Garnier

Onward Technologies

• Onward Technologies Ltd: 1 director by SmartInsider
• Ford Equity International Rating and Forecast Report by Ford Equity Research

Onxeo SA

• VALERIO THERAPEUTICS : RAPPORT DU CONSEIL D’ADMINISTRATION by BusinessWire
• Valerio Therapeutics annonce avoir mis fin au contrat de liquidité conclu le 29 octobre 2018 avec KEPLER CHEUVREUX by BusinessWire
• Valerio Therapeutics annonce un recentrage stratégique by BusinessWire
• End of Coverage by Bryan Garnier
• CIC Market Solutions Morning News Analyser - CIC Market Solutions Morning Analyser - 05/12/2024 by CIC Market Solutions
• Réunion du Conseil d'administration de Valerio Therapeutics S.A. du 13 novembre 2024 by BusinessWire
• Valerio Therapeutics Annonce ses Résultats Financiers du Premier Semestre 2024 et Fait le point sur ses Activités by BusinessWire
• Valerio Therapeutics acquiert Emglev Therapeutics, une société spécialisée dans les thérapies à base d'anticorps à domaine unique by BusinessWire
• Valerio Therapeutics Acquires Emglev Therapeutics, a Single-Domain Antibody-Based Therapeutics Company by BusinessWire
• CIC Market Solutions Morning News Analyser - CIC Market Solutions Morning Analyser - 30/08/2024 by CIC Market Solutions

ONYX ACQUISITION CO I